# Novel Imaging Markers in SPMS

> **NCT05357833** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Utah** · enrollment: 11 (actual)

## Conditions studied

- Secondary Progressive Multiple Sclerosis
- Multiple Sclerosis, Secondary Progressive
- Multiple Sclerosis

## Interventions

- **DRUG:** Ferumoxytol infusion
- **DRUG:** Gadoteridol
- **DIAGNOSTIC_TEST:** MRI Brain and Cervical Spine

## Key facts

- **NCT ID:** NCT05357833
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2023-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05357833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05357833, "Novel Imaging Markers in SPMS". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05357833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*